Novavax Inc. Reports Q2 2026 Financial Results

What Happened Novavax, Inc. announced its financial results for the quarter ended June 30, 2026 in a press release issued and filed on August 6, 2026. The Company reported these results under Item 2.02 (Results of Operations and Financial Condition) of a Current Report on Form 8-K and attached the press release as an exhibit.

Key Details

• Press release announcing Q2 2026 results was issued and filed on August 6, 2026.
• The results cover the quarter ended June 30, 2026.
• The Form 8-K reports Item 2.02 (results of operations) and Item 9.01 (exhibits); the press release is filed as Exhibit 99.1.
• The filing includes an Inline XBRL cover page (Exhibit 104).

Why It Matters This 8-K is the Company’s timely public disclosure of its quarterly earnings and financial condition. Retail investors should review the attached press release (Exhibit 99.1) for specifics on revenue, net income or loss, cash position, and any business or product updates announced for Q2 2026. For full financial statements and management discussion, investors should also watch for the company’s subsequent quarterly report (Form 10-Q) and any related investor materials.